港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MIRXES-B

59.900

-1.900-3.07%

成交量：82.32萬

成交額：4,945.65萬

市值：165.32億

市盈率：-77.89

高：62.150

開：62.150

低：59.000

收：61.800

52周最高：77.300

52周最低：27.050

股本：2.76億

香港流通股本：2.76億

量比：1.56

換手率：0.30%

股息：- -

股息率：- -

每股收益(LYR):-0.769

淨資產收益率：--

總資產收益率：-51.53%

市淨率：20.37

市盈率(LYR):-77.89

市銷率: 100.42

資料載入中...

總覽公司新聞資訊公告

MIRXES-B附屬與印尼公司簽署癌症早檢合作諒解備忘錄

MIRXES-B（02629）累漲93%創新高：技術與資本共振「震盪-突破」循環

MIRXES-B(02629)附屬與一間印尼上市公司訂立一份諒解備忘錄

港股異動 | MIRXES-B(02629)漲近9%創新高公司在基於miRNA的癌症早期檢測領域優勢顯著

MIRXES-B08月11日主力淨流入4.7萬元散户資金拋售

MIRXES-B08月06日主力淨流入44.5萬元散户資金拋售

MIRXES-B07月31日主力淨流出61萬元散户資金買入

覓瑞、NAGAWA聯合發起萬人癌篩，鳩山由紀夫應邀助力亞洲癌症預防

MIRXES-B07月24日主力淨流出115.4萬元散户資金買入

《大行》國證國際：22只非A+H股份可望成為港股通新貴當中15只在今年新上市

覓瑞MIRXES：「借道」「零人」第三方「擦邊」佈局限制類業務

MIRXES-B07月14日遭主力拋售133.2萬元

MIRXES-B07月10日遭主力拋售152.6萬元

覓瑞MIRXES：自詡「唯一獲批」現信披疑雲核心產品特異性或低於國內兩款產品

MIRXES-B(02629)股價下跌8.219%，現價港幣$30.15

阿斯达克财经

醫療IPO沸騰了

MIRXES-B07月02日遭主力拋售126.9萬元

覓瑞MIRXES：核心產品胃癌早篩市場開拓之「困」

覓瑞MIRXES：核心產品胃癌早篩市場開拓之「困」

MIRXES-B06月25日遭主力拋售163.6萬元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02629/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":59.9,"timestamp":1763107691007,"preClose":61.8,"halted":0,"volume":823200,"delay":0,"floatShares":276000000,"shares":276000000,"eps":-0.76899,"marketStatus":"已收盤","change":-1.9,"latestTime":"11-14 16:08:11","open":62.15,"high":62.15,"low":59,"amount":49456525,"amplitude":0.050971,"askPrice":59.9,"askSize":700,"bidPrice":59.65,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.558151,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":61.8,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.561812,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276000000,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":1.561812,"shares":276000000,"dividePrice":0,"high":62.15,"amplitude":0.050971,"preClose":61.8,"low":59,"week52Low":27.05,"pbRate":"20.37","psRate":"100.42","week52High":77.3,"institutionHeld":0,"latestPrice":59.9,"committee":-0.076923,"eps":-0.76899,"divideRate":0,"volume":823200,"delay":0,"ttmEps":-0.558151,"open":62.15,"prevYearClose":23.3,"prevWeekClose":63.85,"prevMonthClose":67.95,"prevQuarterClose":61.4,"fiveDayClose":63.85,"twentyDayClose":70.6,"sixtyDayClose":48.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2025-11-13","current":-107.318629,"percent":0.252101,"low":-34.231253,"twenty":-29.342142,"median":-16.014471,"eighty":-11.200928,"high":-10.373055,"avg":-18.871164,"sd":8.301158,"marketCap":16889768010},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-29","current":-19.927844,"twenty":-12.534962,"median":-11.42267,"eighty":-10.837215,"marketCap":11841524145},{"date":"2025-09-05","current":-19.639174,"twenty":-15.876379,"median":-11.649361,"eighty":-10.890619,"marketCap":11678374256},{"date":"2025-09-12","current":-19.500462,"twenty":-16.755738,"median":-11.763715,"eighty":-10.953665,"marketCap":11578379164},{"date":"2025-09-19","current":-23.413745,"twenty":-18.486553,"median":-11.918008,"eighty":-11.048541,"marketCap":13880897747},{"date":"2025-09-26","current":-25.667378,"twenty":-19.506384,"median":-11.983928,"eighty":-11.09201,"marketCap":15222937150},{"date":"2025-10-03","current":-33.789751,"twenty":-19.751895,"median":-12.054377,"eighty":-11.092062,"marketCap":20046350866},{"date":"2025-10-10","current":-31.081374,"twenty":-21.012535,"median":-12.217733,"eighty":-11.099357,"marketCap":18433897286},{"date":"2025-10-17","current":-30.795303,"twenty":-24.490925,"median":-12.444526,"eighty":-11.135571,"marketCap":18242589234},{"date":"2025-10-24","current":-29.480903,"twenty":-26.341784,"median":-12.526178,"eighty":-11.168279,"marketCap":17463692166},{"date":"2025-10-31","current":-31.356875,"twenty":-27.937945,"median":-12.547947,"eighty":-11.182791,"marketCap":18570545895},{"date":"2025-11-07","current":-29.443096,"twenty":-29.330719,"median":-14.698348,"eighty":-11.200916,"marketCap":17450027305},{"date":"2025-11-13","current":-28.515386,"twenty":-29.342142,"median":-16.014471,"eighty":-11.200928,"marketCap":16889768010}],"updateTime":1763112874268},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560992414","title":"MIRXES-B附屬與印尼公司簽署癌症早檢合作諒解備忘錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2560992414","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560992414?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 15:24","pubTimestamp":1755415453,"startTime":"0","endTime":"0","summary":"8月15日，MIRXES-B（02629）发布公告，公司的间接全资附属公司MiRXESPTE.LTD.与印尼上市公司PTDIASTIKABIOTEKINDO签订了一份为期12个月的谅解备忘录，双方将就高发病率及高死亡率癌症的早期检测及诊断进行合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508173486139020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2559928279","title":"MIRXES-B（02629）累漲93%創新高：技術與資本共振 「震盪-突破」 循環","url":"https://stock-news.laohu8.com/highlight/detail?id=2559928279","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559928279?lang=zh_tw&edition=fundamental","pubTime":"2025-08-16 20:40","pubTimestamp":1755348001,"startTime":"0","endTime":"0","summary":"港股生物科技板块于8月15日再现强势标的——MIRXES-B，盘中一度冲高至44.98港元，刷新上市以来历史高点，较IPO发行价23.3港元累计涨幅已超93%，成为近期医药新股中的领涨品种。MIRXES-B作为“迎通概念”股，入通似乎已是板上钉钉。公开资料显示，MIRXES-B上市初期就凭借“惜货回拨”助推股价上涨。果不其然，MIRXES-B暗盘暴涨33.91%，首日涨幅28.76%。综上，MIRXES-B自上市以来呈现典型的“震荡洗盘—强势突破”周期循环，资金操盘手法高度结构化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2559914384","title":"MIRXES-B(02629)附屬與一間印尼上市公司訂立一份諒解備忘錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2559914384","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559914384?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 20:50","pubTimestamp":1755262210,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MIRXES-B 公布，公司的间接全资附属公司MiRXES PTE. LTD.近期已与PT DIASTIKA BIOTEKINDO订立一份谅解备忘录，据此，双方同意在印尼进行用于高发病率及高死亡率癌症早期检测及诊断的分子诊断检测及相关仪器的注册及商业化方面进行合作。谅解备忘录期限自签署日期起计为期12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2559996010","title":"港股異動 | MIRXES-B(02629)漲近9%創新高 公司在基於miRNA的癌症早期檢測領域優勢顯著","url":"https://stock-news.laohu8.com/highlight/detail?id=2559996010","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559996010?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 11:03","pubTimestamp":1755227035,"startTime":"0","endTime":"0","summary":"公开资料显示，Mirxes觅瑞是一家以新加坡为总部的RNA生物科技公司，致力于开发及商业化针对癌症及其他疾病早期筛查的精准、无创、可负担的血液miRNA检测。公司旗舰产品GASTROClear/觅小卫是一款基于血液miRNA的胃癌筛查分子检测试剂盒，已在包括新加坡及欧盟的多国获批，并取得美国FDA突破性医疗器械认证。国元国际认为，公司在基于miRNA的癌症早期检测领域具有显著的技术、产品和市场优势，是该领域的全球领导者之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2558652879","title":"MIRXES-B08月11日主力淨流入4.7萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2558652879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558652879?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 16:15","pubTimestamp":1754900109,"startTime":"0","endTime":"0","summary":"08月11日, MIRXES-B股价涨0.91%，报收33.16元，成交金额1482.9万元，换手率0.16%，振幅6.21%，量比1.68。MIRXES-B今日主力资金净流入4.7万元，上一交易日主力净流出0万元。该股近5个交易日上涨6.16%，主力资金累计净流出26.8万元；近20日主力资金累计净流出842.4万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811164834a4819e29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811164834a4819e29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2557408327","title":"MIRXES-B08月06日主力淨流入44.5萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2557408327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557408327?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 16:15","pubTimestamp":1754468150,"startTime":"0","endTime":"0","summary":"08月06日, MIRXES-B股价涨4.26%，报收32.80元，成交金额719.5万元，换手率0.08%，振幅4.45%，量比0.74。MIRXES-B今日主力资金净流入44.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨6.67%，主力资金累计净流出57.1万元；近20日主力资金累计净流出1187.3万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170752a6d63a6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170752a6d63a6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2555227000","title":"MIRXES-B07月31日主力淨流出61萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2555227000","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555227000?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 16:15","pubTimestamp":1753949718,"startTime":"0","endTime":"0","summary":"07月31日, MIRXES-B股价跌0.65%，报收30.55元，成交金额570.6万元，换手率0.07%，振幅1.95%，量比0.54。MIRXES-B今日主力资金（超大单+大单）净流出61万元，上一交易日主力净流出0万元。|07月31日主力加仓幅度排名||#|股票简称|主力净额占比|#|宏基集团控股|2.81%|#|高地股份|2.07%|#|嘉鼎国际集团|2.02%|#|...|...|#2204|MIRXES-B|-0.01%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731170027a46d31bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731170027a46d31bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2554175330","title":"覓瑞、NAGAWA聯合發起萬人癌篩，鳩山由紀夫應邀助力亞洲癌症預防","url":"https://stock-news.laohu8.com/highlight/detail?id=2554175330","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554175330?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 12:04","pubTimestamp":1753416253,"startTime":"0","endTime":"0","summary":"7月23日，在日本第93代内阁总理大臣鸠山由纪夫的见证下，新加坡RNA液体活检领域上市企业Mirxes觅瑞集团与日本生物医药企业 NAGAWA 药品株式会社联合发起万人筛查项目，并签署战略合作备忘录。该项合作也整合了觅瑞创新的miRNA 检测技术、NAGAWA 本地化制造和市场推广优势，标志着亚洲癌症早筛领域进入技术 + 产业 + 慈善协同发展的新阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725120726a4627ca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725120726a4627ca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2553620244","title":"MIRXES-B07月24日主力淨流出115.4萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553620244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553620244?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 16:16","pubTimestamp":1753344962,"startTime":"0","endTime":"0","summary":"07月24日, MIRXES-B股价跌0.97%，报收30.55元，成交金额1788.1万元，换手率0.21%，振幅5.67%，量比1.18。MIRXES-B今日主力资金净流出115.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌7.42%，主力资金累计净流出77.4万元；近20日主力资金累计净流出1871.2万元，其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170432a460f04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170432a460f04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2553473223","title":"《大行》國證國際：22只非A+H股份可望成為港股通新貴 當中15只在今年新上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2553473223","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553473223?lang=zh_tw&edition=fundamental","pubTime":"2025-07-21 11:31","pubTimestamp":1753068682,"startTime":"0","endTime":"0","summary":"国证国际发表研究报告指，恒指公司将于8月22日发布上半年检讨结果，相关变动将于9月8日生效。由于恒生综合指数的变动将影响港股通名单，其变动受到投资者的高度重视。该行基于平均市值及换手率两个指标计算，得出22只非A+H股份可望成为港股通新贵，当中15只在今年新上市。该行未有计入东亚银行，虽然该股的市值达标，但可能因换手率不足而未能重获港股通资格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721175701a6b7b5d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721175701a6b7b5d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02473","06613","06168","02007","00506","603345","CTRYY","03288","06681","603288","02609","01783","02643","CHFHY","02610","02050","01729","02589","03677","02648","BK4177","09606","02276","YANG","02629","01333","09678","06603","BK4614"],"gpt_icon":0},{"id":"2551005113","title":"覓瑞MIRXES：「借道」「零人」第三方 「擦邊」佈局限制類業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2551005113","media":"金证研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551005113?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 09:18","pubTimestamp":1752628680,"startTime":"0","endTime":"0","summary":"基于上述情形，觅瑞或“左手倒右手”，“借道”宝晟“擦边”实现上述业务布局。紧随上述股权转让完成后，嘉年分别由杭州觅瑞健康及杭州觅因持有70%及30%。觅瑞披露称，由于相关业务及运营根据中国法律受外商投资限制，嘉年于2023年11月6日订立加入杭州合约安排的加入协议。可见，上市前，觅瑞通过置出子公司的方式，不再从事外商限制类或禁止类业务。对于受让方宝晟，觅瑞称其系独立第三方。嘉年属于双方合资的企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071609191995442ae0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071609191995442ae0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2551188785","title":"MIRXES-B07月14日遭主力拋售133.2萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551188785?lang=zh_tw&edition=fundamental","pubTime":"2025-07-14 16:15","pubTimestamp":1752480919,"startTime":"0","endTime":"0","summary":"07月14日，MIRXES-B股价收平报30.85元，成交金额762.0万元，换手率0.09%，振幅2.43%，量比0.57。MIRXES-B今日主力资金净流出133.2万元，上一交易日主力净流出130.5万元。该股近5个交易日下跌0.48%，主力资金累计净流出597.8万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出4593.1万元，其中净流出天数为19日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714165604a44975a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714165604a44975a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2550617370","title":"MIRXES-B07月10日遭主力拋售152.6萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550617370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550617370?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 16:15","pubTimestamp":1752135351,"startTime":"0","endTime":"0","summary":"07月10日, MIRXES-B股价跌1.12%，报收31.00元，成交金额902.5万元，换手率0.10%，振幅4.78%，量比0.61。MIRXES-B今日主力资金净流出152.6万元，上一交易日主力净流出113.0万元。该股近5个交易日下跌3.09%，主力资金累计净流出701.7万元，其中3个交易日为股价上涨时净流出；近20日主力资金累计净流出4330.5万元，其中净流出天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710170034a6a13ba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710170034a6a13ba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2550656935","title":"覓瑞MIRXES：自詡「唯一獲批」現信披疑雲 核心產品特異性或低於國內兩款產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656935","media":"金证研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550656935?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 22:25","pubTimestamp":1752071114,"startTime":"0","endTime":"0","summary":"而在上述两款产品或均属于用于胃癌筛查的分子诊断IVD产品的情况下，觅瑞自称系全球范围内唯一一家获得分子胃癌筛查IVD产品监管批准的公司，信息披露现疑云。在此情况下，觅瑞的核心产品的特异性，或低于国内两款胃癌基因甲基化检测产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709223045a44091ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709223045a44091ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2549458598","title":"MIRXES-B(02629)股價下跌8.219%，現價港幣$30.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2549458598","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549458598?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 15:35","pubTimestamp":1751873700,"startTime":"0","endTime":"0","summary":"[下跌股]MIRXES-B(02629) 股价在下午03:35比前收市价下跌8.219%，现股价为港币$30.15。至目前为止，今日最高价为$32.85，而最低价为$30.15。总成交量为50.42万股，总成交金额为港币$1.583千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2507072205/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2548841699","title":"醫療IPO沸騰了","url":"https://stock-news.laohu8.com/highlight/detail?id=2548841699","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548841699?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 08:35","pubTimestamp":1751502900,"startTime":"0","endTime":"0","summary":"医疗IPO市场热潮再起，迎来高光时刻。在2025年上半年港股完成的IPO中，医疗健康企业以9家的数目独占鳌头，成为当之无愧的IPO数量之最行业。同时，A股科创板也重新为医疗企业敞开了IPO大门。如今，历经两年的蛰伏与磨砺，医疗健康IPO终于迎来了破晓的曙光。从细分行业来看，创新药无疑撑起了本轮港股医疗健康IPO的繁荣。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703083915a72b749b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703083915a72b749b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK0188","LU0405327494.USD","LU1064131003.USD","LU1064130708.USD","LU1997245177.USD","LU2495084118.USD","BK0183","02315","BK0239","LU2148510915.USD","LU1997244956.HKD","BK0060","159891","01276","BK0012","BK0196","LU1997245094.SGD","LU2488822045.USD","LU1655091616.SGD","LU1969619763.USD","LU1328615791.USD","02629","LU2328871848.SGD","BK0028","600276","LU0405327148.USD"],"gpt_icon":0},{"id":"2548867483","title":"MIRXES-B07月02日遭主力拋售126.9萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548867483?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 16:15","pubTimestamp":1751444157,"startTime":"0","endTime":"0","summary":"07月02日, MIRXES-B股价跌4.93%，报收32.80元，成交金额3381.2万元，换手率0.36%，振幅7.10%，量比0.88。MIRXES-B今日主力资金净流出126.9万元，连续3日净流出，上一交易日主力净流出432.0万元。该股近5个交易日下跌3.95%，主力资金累计净流入218.1万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出2126.4万元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702171241a72a43b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702171241a72a43b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2548133040","title":"覓瑞MIRXES：核心產品胃癌早篩市場開拓之「困」","url":"https://stock-news.laohu8.com/highlight/detail?id=2548133040","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548133040?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 09:54","pubTimestamp":1751334884,"startTime":"0","endTime":"0","summary":"而总部位于新加坡的Mirxes Holding Company Limited，其核心产品系用于胃癌筛查的基于血液的miRNA检测组。对此，觅瑞称，目前，其产品及服务并不受觅瑞商业化产品及服务的国家的公共医疗保险计划保障。此外，RS19基因甲基化可用于检测早期胃癌，阳性受检者应及时进行胃镜检查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507010956349531ef84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507010956349531ef84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2546534847","title":"覓瑞MIRXES：核心產品胃癌早篩市場開拓之「困」","url":"https://stock-news.laohu8.com/highlight/detail?id=2546534847","media":"金证研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546534847?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 01:30","pubTimestamp":1750959046,"startTime":"0","endTime":"0","summary":"作为一种在胃黏膜上形成恶性细胞的疾病，胃癌由于早期症状通常被视作普通肠胃问题，因此难以发现。而总部位于新加坡的Mirxes Holding Company Limited，其核心产品系用于胃癌筛查的基于血液的miRNA检测组。2025年5月23日，觅瑞成功在港交所上市挂牌，自上市以来至2025年6月26日，其股价涨幅超40%。此外，专家共识意见指出，现阶段国内胃癌早筛流程主要系血清学免疫检测。而近三年，觅瑞累计亏损超2亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/27013051332656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2546213573","title":"MIRXES-B06月25日遭主力拋售163.6萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546213573","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546213573?lang=zh_tw&edition=fundamental","pubTime":"2025-06-25 16:15","pubTimestamp":1750839333,"startTime":"0","endTime":"0","summary":"06月25日, MIRXES-B股价跌0.59%，报收33.95元，成交金额3052.9万元，换手率0.32%，振幅1.46%，量比0.59。MIRXES-B今日主力资金净流出163.6万元，上一交易日主力净流出182.9万元。该股近5个交易日下跌1.59%，主力资金累计净流出1730.4万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出269.0万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625173008a71cc83f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625173008a71cc83f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":111,"code":"91000000","status":"200"}]}}